» Articles » PMID: 16377077

Single Nucleotide Polymorphisms in ABCC2 and ABCB1 Genes and Their Clinical Impact in Physiology and Drug Response

Overview
Journal Cancer Lett
Specialty Oncology
Date 2005 Dec 27
PMID 16377077
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Among the ABC proteins, some members including ABCB1, ABCC1, ABCC2 and ABCG2 are believed to contribute to multidrug resistance of cancer chemotherapy. In addition, the broad substrate-specificity and apical localization of the ABCB1 and ABCC2 in mucosal epithelium of intestine and hepatocyte give them a protective role against xenobiotics. The inter-individual variations in activity and expression levels of ABCB1 and ABCC2, thus, might affect on drug response and response to toxic substrates. In this review, I focus on (1) physiological and toxicological relevance of ABCB1 and ABCC2, and on (2) genetic variations of ABCB1 and ABCC2 genes and their association with biochemical function, expression level and tumor incidence.

Citing Articles

ABCG2 confers promotion in gastric cancer through modulating downstream CRKL in vitro combining with biostatistics mining.

Wang J, Yunyun Z, Wang L, Chen X, Zhu Z Oncotarget. 2016; 8(3):5256-5267.

PMID: 28029654 PMC: 5354906. DOI: 10.18632/oncotarget.14128.


Genetic Variations of Drug Transporters Can Influence on Drug Response in Patients Treated with Docetaxel Chemotherapy.

Choi J, Kim J, Kang D, Shin J, Zhang X, Oh J Cancer Res Treat. 2015; 47(3):509-17.

PMID: 25648089 PMC: 4506105. DOI: 10.4143/crt.2014.012.


PharmGKB summary: cyclosporine and tacrolimus pathways.

Barbarino J, Staatz C, Venkataramanan R, Klein T, Altman R Pharmacogenet Genomics. 2013; 23(10):563-85.

PMID: 23922006 PMC: 4119065. DOI: 10.1097/FPC.0b013e328364db84.


Transporter-mediated Efflux Influences CNS Side Effects: ABCB1, from Antitarget to Target.

Broccatelli F, Carosati E, Cruciani G, Oprea T Mol Inform. 2012; 29(1-2):16-26.

PMID: 22347894 PMC: 3281213. DOI: 10.1002/minf.200900075.


Common variants in ABCB1, ABCC2 and ABCG2 genes and clinical outcomes among women with advanced stage ovarian cancer treated with platinum and taxane-based chemotherapy: a Gynecologic Oncology Group study.

Tian C, Ambrosone C, Darcy K, Krivak T, Armstrong D, Bookman M Gynecol Oncol. 2011; 124(3):575-81.

PMID: 22112610 PMC: 3278512. DOI: 10.1016/j.ygyno.2011.11.022.